The Division of Research's Douglas Corley will be responsible for developing and implementing a new research program in The Permanente Medical Group that will advance the creation of evidence-driven strategies to improve the delivery of health care.
Neurologists of the Kaiser Permanente Northern California Stroke FORCE team get clot-busting alteplase to patients twice as fast as the national average.
DOR's Theodore (TR) Levin, MD, is one of four recipients of The Permanente Medical Group's 2018 Sidney R. Garfield Exceptional Contribution Awards, for pioneering efforts to expand colorectal cancer screening.
Women with gestational diabetes who received a tailored letter with personalized weight-gain recommendations were significantly more likely to meet national weight-gain guidelines, according to a Kaiser Permanente study published in Diabetes Care.
A study of diabetes patients at Kaiser Permanente suggests that severe episodes of hypoglycemia occur far more often than is captured in electronic medical records, pointing to a nationwide need for improved tracking of these events.
Death rates from heart disease and stroke in adults under age 65 are lower and dropping faster for Kaiser Permanente members in Northern California than in the rest of the United States, according to new research published today in the American Journal of Medicine.
The second Cardiovascular Research Symposium drew approximately 80 people including researchers, sub-specialty physicians, quality and operational staff, and others from across Kaiser Permanente’s Northern California region. It was convened at the Division of Research (DOR) in Oakland by Alan S. Go, MD, DOR’s associate director of Cardiovascular and Metabolic Conditions Research.
Every three years since 1993, the Member Health Survey has been reaching out to members to find out what they are doing — and not doing — to stay healthy, helping Kaiser Permanente to better understand its membership and how to serve their health needs.
The Division of Research’s Stephen Sidney, MD, MPH was honored by the National Forum for Heart Disease and Stroke Prevention for his “exceptional contributions” as well as his work on understanding national trends in cardiovascular disease.
As a research scientist for the Kaiser Permanente Northern California Division of Research and director of KP’s Vaccine Study Center, it’s Nicola Klein's job to study the safety and effectiveness of both new and older vaccines.